Beta blockers after myocardial infarction: have trials changed practice?
A survey of British consultant cardiologists was carried out to elicit their current practices when prescribing long term beta blockers after myocardial infarction. Sixty (72%) of the respondents reported that they used beta blockers prophylactically even in the absence of any other indications; the details of their stated policies, however, varied considerably. The favourable evidence of clinical trials in this indication appears to have been assimilated into hospital practice.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000368:Aged; D006801:Humans; D008134:Long-Term Care; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control*
D000319:Adrenergic beta-Antagonists